Fortress Biotech (FBIO) CFO Robyn Hunter Sells 20,370 Shares

Fortress Biotech (FBIO) CFO Robyn Hunter Sells 20,370 Shares


Fortress Biotech CFO Robyn Hunter sold 20,370 shares of the company's stock in a transaction dated Friday, November 23rd. The shares were sold at an average price of $1.29, for a total transaction of $26,277.30.



from Biotech News
Share:

FDA approves Meridian Bioscience's test for herpes in newborns

FDA approves Meridian Bioscience's test for herpes in newborns


REUTERS: The U.S. Food and Drug Administration approved on Friday the first test: a diagnostic from Meridian Bioscience Inc: to help detect a type of herpes virus in newborns. Meridian's Alethia CMV Assay Test System detects cytomegalovirus DNA from saliva swabs and won approval for use in babies younger than 21 days of age infected during pregnancy.



from Biotech News
Share:

US Biotech Firms Made China's Gene-Edited Babies Possible

US Biotech Firms Made China's Gene-Edited Babies Possible


Combined with other changes that had sprung biology free from the ivory tower, the concern was that someone with a modicum of expertise would go rogue and start a Crispr-It-Yourself baby project. Only three years later, we now know that someone is named He Jiankui.



from Biotech News
Share:

Should PoMo Architecture, at the 50-Year Mark, Be Saved?

Should PoMo Architecture, at the 50-Year Mark, Be Saved?


Post-Modernist buildings, those teasing, colorful mash-ups of columns, pilasters and pediments, were both praised and reviled in the 1970s and '80s, their heyday. But by the end of the '80s they fell out of fashion, consigned with surprising abruptness to the dustbin of architectural history.



from Biotech News
Share:

Primecap Management Co. CA Has $987.71 Million Stake in Alkermes Plc

Primecap Management Co. CA Has $987.71 Million Stake in Alkermes Plc


Primecap Management Co. CA decreased its stake in shares of Alkermes Plc by 0.3% in the 3rd quarter, according to its most recent 13F filing with the SEC.



from Biotech News
Share:

Outside the Box: Chinese biotech stocks hit by a double whammy, which means it's time to buy

Outside the Box: Chinese biotech stocks hit by a double whammy, which means it's time to buy


Have investors hit peak negativity on China-based companies? I think there's a good chance they have. If so, it's time to buy China stocks, especially in biotechnology.



from Biotech News
Share:

Progenics Pharmaceuticals, Inc. (PGNX) Given Consensus Recommendation of "Buy" by Brokerages

Progenics Pharmaceuticals, Inc. (PGNX) Given Consensus Recommendation of "Buy" by Brokerages


Progenics Pharmaceuticals, Inc. has received an average recommendation of "Buy" from the six research firms that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the company.



from Biotech News
Share:

Eli Lilly And Co (LLY) Given Average Recommendation of "Buy" by Brokerages

Eli Lilly And Co (LLY) Given Average Recommendation of "Buy" by Brokerages


Shares of Eli Lilly And Co have earned an average recommendation of "Buy" from the twenty-two brokerages that are presently covering the firm, Marketbeat Ratings reports. Nine equities research analysts have rated the stock with a hold recommendation and twelve have given a buy recommendation to the company.



from Biotech News
Share:

Finanzen: Modernisierungsmaßnahmen in der Mietwohnung : Mieterhöhung nach Modernisierung

Steht eine Sanierung der Wohnung an, müssen sich Mieter auf Lärm, Dreck und eine höhere Miete einstellen. Der Vermieter muss die Baumaßnahmen aber ankündigen und darf bloße Reparaturkosten nicht auf den Mieter umlegen.

from Finanztip Feed
Supported by Video Collection
Share:

La Jolla art gallery owner charged with trafficking ivory

La Jolla art gallery owner charged with trafficking ivory


The Carlton Gallery in La Jolla, its owner and an employee are facing criminal charges for allegedly trafficking $1.3 million in illegal ivory, San Diego City Attorney Mara Elliott announced Wednesday. Elliott's office has been investigating the Carlton Gallery since May 2017 and performed a sting operation on the business on May 1 of this year, with the help of wildlife officers from the state Department of Fish and Wildlife.



from Biotech News
Share:

Finanzen: Mietpreisbremse : Mietpreisbremse

In über 300 Städten müssen sich Vermieter bei einer Neuvermietung an die Mietpreisbremse halten. Mieter sollten ihre Rechte kennen und nicht jeden Mietpreis akzeptieren.

from Finanztip Feed
Supported by Video Collection
Share:

a 30m for Dublin biotech firm founded by Trinity graduate

a 30m for Dublin biotech firm founded by Trinity graduate


A groundbreaking Dublin biotech firm, backed in part by Bono and The Edge, has won a 30m in financing from the European Investment Bank in its first direct financing for an Irish firm in the sector. A groundbreaking Dublin biotech firm, backed in part by Bono and The Edge, has won a 30m in financing from the European Investment Bank in its first direct financing for an Irish firm in the sector.



from Biotech News
Share:

Сезон 2018-2019: цены на скипассы в Гудаури

Горнолыжный курорт Гудаури

Гудаури - молодой развивающийся горнолыжный курорт, находится в Казбегском районе Грузии в 120 км от Тбилиси на высоте 2196 м, вблизи Крестового перевала. Координаты курорта 42°27'39" с.ш., 44°28'59" в.д. (парковка у отеля Марко Поло, WGS84). Самой главной достопримечательностью Гудаури является фрирайд - спуск по целинным полям. Глубокий снежный покров, отсутствие камней, лавинной опасности делают Гудари Меккой фрирайда. Также вокруг курорта огромное количество внетрассовых спусков для беккантри и хели-ски. 

Горнолыжный курорт Гудаури - Карта Горнолыжных Трасс


О Снеге:  Горнолыжный сезон в Гудаури продолжается с второй половины декабря по май, в это время возможно комфортное катание на всех трассах. В снежные годы в ноябре и мае возможно катание на третьей, пятой очереди.
В сезоне 2014-15 была успешно запущена система искусственного  оснежнения трассы первой очереди. 

Когда начало катания зимнего сезона 2018-2019 в Гудаури?

- Снег выпал 12 ноября (ссылка). Откроется ли курорт раньше официальной даты открытия?-Может ответить только небесная канцелярия, а мы будем надеяться. Сезоны 2016-2017-18 открыты 10 декабря, раньше планируемого срока, из-за очень большого количества снега ...тьфутьфу Сезоны 2014-15-16 были очень снежными.  До 2014-15 несколько лет отмечалась снежная аномалия: Сезон 2013-14: официально открыт 25 января, но канатки работали с конца декабря и снег для катания был на самом верху. Сезон 2011-2012: на НГ снег для катания на третьей очереди был, по мнению старожилов, но администрация курорта включила канатки 10 января. Сезон 2010-2011, снег в Гудаури появился 26 января.  



Трассы и подъемники в Гудаури

Нижняя станция подъемника находится на высоте 1990м, а верхняя на 3307м. Подъемники Doppelmayer, Poma. Протяженность трасс 50 км. Общее число трасс 22. Подъемники курорта могут одновременно обслуживать 11000 людей. 218 гектар трасс каждую ночь обрабатываются ратраками. 20% трасс для профессионалов 80% - для любителей.  На первой трассе установлены снежные пушки.

Первая : "Пирвели" 1992-2065м- 3 кресла (со снежными пушками и вечером освещена),
вторая: "Солико" 2157-2709м- 3 кресла,
третья: "Кудеби" 2703-3006м - 3 кресла, (на вершину Кудеби)
"Сноу Парк"- 3 кресла, 2720-2846м
=  "Садзеле"- 4 кресла, 2795-3276м, (на соседнюю вершину Садзеле).
гондольная канатная дорога "Гудаура" - 2724-2777м, 10 человек,
"Шино"-, 6 кресел, 2186-2724
учебный склон "Зума" с бугельным подъемником POMA- 2151-2210м 
Альпина: 2300-2320м
Бомбора: 2740-2780
Baby
Цены на подъемники на Горнолыжном Курорте Гудаури в Грузии
  • Сноу-парк для экстримального катания 
  • Тюбинговая трасса и бегущая дорожка (SunKid people mover) - 300м. Бесплатны для посетителей курорта.


    Расписание работы подъемников в Гудаури, Грузия

    Подъемники работают независимо от количества катающихся, на данной очереди. Закрываются они лишь по погодным условиям, при очень плохой видимости или сильном ветре. На случай отключения электричества канатные дороги оборудованы аварийными дизелями.
    • Зимой: с 10 до 17 часов. 
    • Март 2018 9:00 -16:00. Весной (апрель, конец марта): пн.-пятн.: 9:00 -15:00 суб. воскр.: 9:00 -16:00.  
    • Цены Лета 2019: Одна поездка – 5 Gel Садзеле (Gudaura, Snow Park, Sadzele) – 15 Gel Велосипедный проездной на 1 день – 12 Gel Проездной на все лето– 60 Gel 20% скидка для групп 10-20 человек, 30% для групп от 20 человек. Велотрасса скоростного спуска длиной 4790м.
    Вечернее катание на первой трассе по субботам 20:00 -22:00.

    Подготовлено по материалам сайта: Гудаури.инфо


from Мобильный Путешественник https://ift.tt/2DTcDZh
via Video Collection
Share:

Finanzen: Freibeträge und Pauschbeträge : Steuerfreibetrag

Pauschbeträge und Freibeträge kommen für viele Steuerzahler infrage. Belege sind hierfür nicht nötig.

from Finanztip Feed
Supported by Video Collection
Share:

German pharmaceutical company Bayer cutting 12,000 jobs

German pharmaceutical company Bayer cutting 12,000 jobs


In this May 25, 2018 file photo members of the supervisory board sit in front of the company logo during the annual shareholders meeting of German chemical giant Bayer AG in Bonn, Germany. Bayer said Thursday, Nov 29, 2018 it will cut 12 000 jobs, most of them in Germany.



from Biotech News
Share:

Bayer plant Abbau von 12.000 Stellen weltweit

Bayer plant Abbau von 12.000 Stellen weltweit


(dpa) Bayer will mehr als jede zehnte Stelle weltweit streichen. Insgesamt sollen bis Ende 2021 rund 12.000 der 118.200 Arbeitsplätze abgebaut werden. «Ein signifikanter Teil» der Stellenstreichungen werde in Deutschland erfolgen, teilte das Unternehmen am Donnerstag mit. Genaue Zahlen für Deutschla...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Berkshire Sterile Manufacturing Announces Promotion of Debbie Smith to Vice President of Quality Assurance

Berkshire Sterile Manufacturing Announces Promotion of Debbie Smith to Vice President of Quality Assurance


Berkshire Sterile Manufacturing in Lee Massachusetts announces the promotion of Debbie Smith to Vice President of Quality Assurance, where she will provide executive leadership to the management of all quality oversight activities and development and maintenance of BSM's Quality Systems. Debbie has over fourteen years of extensive quality experience in the pharmaceutical and Biotechnology industries, with a focus on aseptic commercial production.



from Biotech News
Share:

Suicide, Overdoses Help Cut US Life Expectancy

Suicide, Overdoses Help Cut US Life Expectancy


Suicides and drug overdoses helped lead a surge in U.S. deaths last year, and drove a continuing decline in how long Americans are expected to live. Overall, there were more than 2.8 million U.S. deaths in 2017, or nearly 70,000 more than the previous year, the Centers for Disease Control and Prevention said Thursday.



from Biotech News
Share:

Merck raised prices five drugs including Keytruda in November

Merck raised prices five drugs including Keytruda in November


Merck & Co Inc said on Wednesday it raised U.S. prices on five of its drugs earlier in November by between 1.5 percent and 6 percent, including its top-selling cancer treatment Keytruda. NEW YORK: Merck & Co Inc said on Wednesday it raised U.S. prices on five of its drugs earlier in November by between 1.5 percent and 6 percent, including its top-selling cancer treatment Keytruda.



from Biotech News
Share:

TRAVEL NEWS about MUST VISIT venues in Tbilisi from Welcome to Georgia!

პროექტის მედია პარტნიორი - Travel News Magazine, თქვენი მომდევნო მოგზაურობის შთაგონების წყარო და თბილისის აუცილებლად სანახვი ადგილების გზამკვლევი!


TRAVEL NEWS -  1996 წლიდან ვრცელდება კვარტლური სიხშირით. წამყვანი უკრაინული ჟურნალი, დაუვიწყარი მოგზაურობებისა და ცხოვრების წესის შესახებ, გახდება თქვენი საიმედო გზამკვლევი მსოფლიოს ირგვლივ. მკითხველებისთვის - ჟურნალი არის პრემიუმ კლასის მოგზაურობის, ცხოვრების წესის და ახალი გამოცდილების შთაგონების წყარო: სტატიები და ფოტოსურათები, შექმნილია ცნობილ ბლოგერებთან, ფოტოგრაფებთან და ჟურნალისტებთან თანამშრომლობის შედეგად. 



Welcome to Georgia! ტურიზმის ეროვნული დაჯილდოების პროექტთან თანამშრომლობის შედეგად საქართველო TRAVEL NEWS-ის ფავორიტი დანიშნულება გახდა, ხოლო  ჟურნალის ბოლო გამოცემაში გაეცნობით ძველი თბილისის ახალ სახელებს!

 
თუ გაქვთ ამბიცია იცოდეთ ყველაფერი თბილისის შესახებ, აუცილებლად გაეცანით სტატიას, რათა იცოდეთ ქალაქის ახალი დახვეწილი სასტუმროების შესახებ, იცოდეთ სად შეიძლება შეიგრძნოთ და შეიცნოთ ქართული ღვინის სული და იცოდეთ სად ტარდება ქალაქის ყველაზე მნიშვნელოვანი ღონისძიებები!





Get inspired for luxury traveling and explore MUST VISIT venues in Tbilisi together with TRAVEL NEWS
 Magazine – Media Partner of the Project

 
TRAVEL NEWS – published since 1996 with quarterly frequency is a leading Ukrainian glossy magazine for unforgettable travel experience that will definitely be your reliable guide around the World created as a result of cooperation with famous bloggers, photographers, journalists etc.
For readers – a source of inspiration for luxury traveling, lifestyle and new experience: our articles and shootings are.  For partners – an effective tool for promotion on Ukrainian market.

Ever since the beginning of cooperation with Welcome to Georgia! National Tourism Awards Georgia is on the top of destinations suggested by Travel News Magazine and in the latest issue you are encouraged to explore NEW NAMES of OLD TBILISI

If you have an ambition to know everything about Tbilisi, we insist that you should read an article to know more about new exquisite hotels with mesmerizing city views, about where to feel and learn the spirit of Georgian Wine and know who is hosting the most  GRAND events of the City.


from Мобильный Путешественник https://ift.tt/2PbAPZ7
via Video Collection
Share:

BIO Applauds Inclusion of Pro-Growth Provisions in Tax and Oversight Legislation

BIO Applauds Inclusion of Pro-Growth Provisions in Tax and Oversight Legislation


Nov 28, 2018--This week, the House of Representatives plans to take up a tax and oversight package which includes a provision that would protect investments in start-ups from inadvertently triggering the net operating loss limitations under Section 382 of the tax code. R&D-intensive biotech start-ups frequently accumulate substantial NOLs in their early, pre-revenue years, given their typical reliance on investor capital for more than a decade before realizing any product revenue.



from Biotech News
Share:

NIH and NIMH: We're deeply committed to reducing suicide

NIH and NIMH: We're deeply committed to reducing suicide


From Dr. Francis S. Collins, director of the National Institutes of Health, and Dr. Joshua A. Gordon, director of the National Institute of Mental Health NIH and NIMH: We're deeply committed to reducing suicide From Dr. Francis S. Collins, director of the National Institutes of Health, and Dr. Joshua A. Gordon, director of the National Institute of Mental Health Check out this story on USATODAY.com: https://ift.tt/2RjgRxn Suicide is a human tragedy and a major public health concern, and the National Institutes of Health is deeply committed to bringing the very best science to this critical issue.



from Biotech News
Share:

Deutscher Zukunftspreis 2018 für Virenschutz-Medikament

Deutscher Zukunftspreis 2018 für Virenschutz-Medikament


(dpa) Für ein Medikament zum Schutz vor einem verbreiteten Virus hat ein Team aus Nordrhein-Westfalen den Deutschen Zukunftspreis 2018 erhalten. Bundespräsident Frank-Walter Steinmeier übergab die mit 250.000 Euro dotierte Auszeichnung für Technik und Innovation am Mittwochabend in Berlin. Die Preis...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Former executive at opioid maker Insys to plead guilty

Former executive at opioid maker Insys to plead guilty


A former executive at Insys Therapeutics Inc is expected to plead guilty on Wednesday to charges that he participated in a scheme to bribe doctors to prescribe the company's opioid drug. FILE PHOTO: A box of the Fentanyl-based drug Subsys, made by Insys Therapeutics Inc, is seen in an undated photograph provided by the U.S. Attorney's Office for the Southern District of Alabama.



from Biotech News
Share:

Stada stellt Untersuchungen gegen frühere Vorstände ein

Stada stellt Untersuchungen gegen frühere Vorstände ein


(dpa) Der Arzneihersteller Stada hat Untersuchungen gegen frühere Vorstände eingestellt. Die Aufarbeitung von Vorwürfen gegen den früheren Vorstandschef Matthias Wiedenfels und Ex-Finanzvorstand Helmut Kraft seien abgeschlossen, teilte der Konzern am Mittwoch in Bad Vilbel mit. Es seien «keine geric...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

British genetic database expects $320 million investment

British genetic database expects $320 million investment


U.K. Biobank, a huge collection of patients' health and genetic information, is expected to attract as much as $320 million in investment as Britain tries to bolster its life-sciences sector with Brexit looming. The money is set to come from government, nonprofit and business sources, said John Bell, an Oxford University geneticist tapped by the government to oversee the industry strategy.



from Biotech News
Share:

Western Markets Hold Back Global Growth For Neurology Drugs

Western Markets Hold Back Global Growth For Neurology Drugs


LONDON, GREATER LONDON, UK, November 28, 2018 / EINPresswire.com / -- As a new report, Pharmaceutical Drugs Global Market Opportunities And Strategies To 2021 , from The Business Research Company , shows, North America and Western Europe, the world's two largest markets for neurology drugs to treat diseases of the brain, spinal cord and nerves, are holding back global growth to around 5% annually, despite vigorous growth in other regions. Asia Pacific's market, which is nearly as large as that of Western Europe, will grow at almost 9% year on year to 2021, and so will the smaller market of the Middle East.



from Biotech News
Share:

Finanzen: Lebensversicherung beleihen : Lebensversicherung beleihen

Ein Policendarlehen verschafft auch Menschen mit schlechter Bonität einen Kredit. So finden Sie das beste Angebot.

from Finanztip Feed
Supported by Video Collection
Share:

Markets Right Now: Indexes end a wobbly day mostly higher

Markets Right Now: Indexes end a wobbly day mostly higher


In this Nov. 20, 2018, file photo, a trader works at the New York Stock Exchange. The U.S. stock market opens at 9:30 a.m. EST on Tuesday, Nov. 27. FILE- In this Nov. 20, 2018, file photo, a trader works at the New York Stock Exchange.



from Biotech News
Share:

Finanzen: Vorsicht vor hohen Kosten im Ausland : Rufumleitung

Mit einer Rufumleitung können Sie Anrufe auf ein anderes Gerät umleiten. Wir zeigen Ihnen, wie sich Kosten im In- und Ausland vermeiden lassen.

from Finanztip Feed
Supported by Video Collection
Share:

US stock indexes edge mostly higher a day after a big gain Source: AP

US stock indexes edge mostly higher a day after a big gain Source: AP


Stocks wobbled Tuesday as large high-dividend stocks rose and smaller companies sank. Major indexes were coming off big gains the day before.



from Biotech News
Share:

Bayer will Kosten sparen und Arbeitsplätze abbauen

Bayer will Kosten sparen und Arbeitsplätze abbauen


(dpa-AFX) Der Pharma- und Agrarchemiekonzern Bayer will laut einem Medienbericht Kosten einsparen und dafür auch Arbeitsplätze abbauen. Besonders betroffen sei die kriselnde Sparte Consumer Health, die verschreibungsfreie Medikamente wie Aspirin herstellt, berichtete das "Handelsblatt" am Dienstag m...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Confirmed AFM cases up to 116 in 31 states, CDC says

Confirmed AFM cases up to 116 in 31 states, CDC says


The Centers for Disease Control and Prevention has confirmed 116 cases of Acute Flaccid Myelitis, also known as AFM, in 31 states. Of those, 116 are confirmed, up by 10 from last week.



from Biotech News
Share:

Wie ein kleines Molekül die Entfernung von überschüssigem Cholesterin fördert

Wie ein kleines Molekül die Entfernung von überschüssigem Cholesterin fördert


image description
Wissenschaftler haben die Struktur der aktivierten Form eines Enzyms bestimmt, das hilft, überschüssiges Cholesterin in die Leber zurückzuführen.Die Forschung zeigt, wie eine medikamentenähnliche Chemikalie die Wirkung des Enzyms Lecithin:Cholesterin Acyltransferase (LCAT) stimuliert. Es deutet auch...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Flu - light' now, but could spike

Flu - light' now, but could spike


Flu activity continues to rise in Connecticut, but state officials are back-tracking on previous reports that two people have died related to the flu this season. Nationwide, flu activity "remains low, although small increases in activity were reported," according to the Centers for Disease Control and Prevention's most recent flu report.



from Biotech News
Share:

Pfizer Inc. Issues A Voluntary Nationwide Consumer Level Recall of...

Pfizer Inc. Issues A Voluntary Nationwide Consumer Level Recall of...


Pfizer Consumer Healthcare, a division of Pfizer Inc., is voluntarily recalling six lots of ThermaCare HeatWrap product to the consumer level. Pfizer Consumer Healthcare initiated this recall because product from these lots has a potential to leak ingredients that are contained in the heat cell wrap.



from Biotech News
Share:

New biotech patent makes Spirulina microalgae into a specialty chemical factory

New biotech patent makes Spirulina microalgae into a specialty chemical factory


Lumen Bioscience announced today that the US Patent and Trademark Office has issued a patent for its gene editing and insertion technology that makes the microorganism into a platform that can readily produce biologics, proteins, and other various molecules at commercial scale-some of which are in line to be used in cosmetics and personal care manufacturing. When working with microorganisms like bacteria, fungi, and algae, rather than using plant breeding to changes traits, scientists adjust and edit genes directly.



from Biotech News
Share:

Alcon sees 2020 dividend, bolt-on purchases in life after Novartis

Alcon sees 2020 dividend, bolt-on purchases in life after Novartis


Alcon, which made the announcement on Tuesday ahead of an investor day in New York, is being jettisoned from Novartis's portfolio as Chief Executive Vas Narasimhan focuses on new drugs, not the surgical devices and contact lenses that Alcon makes. The eye care unit, whose sales returned to growth in 2017 after Novartis was forced to invest millions in sales and service staff to arrest declines, could be valued between $20 billion and $30 billion, Novartis officials have said, when it is spun off to shareholders in the first half of 2019.



from Biotech News
Share:

Cases of rare, polio-like condition in U.S. highest since 2016

Cases of rare, polio-like condition in U.S. highest since 2016


A rare, polio-like condition has sickened 116 people in the United States so far this year, the highest number of cases since 2016, the U.S. Centers for Disease Control and Prevention said on Monday. FILE PHOTO: A general view of the Centers for Disease Control and Prevention headquarters in Atlanta, Georgia September 30, 2014.



from Biotech News
Share:

Former Aveo exec resigns as ImmunoGen CFO after fraud verdict

Former Aveo exec resigns as ImmunoGen CFO after fraud verdict


The chief financial officer of Waltham-based ImmunoGen has stepped down after a jury found him liable for defrauding investors at his previous company. David Johnston was one of three former Aveo Pharmaceuticals executives accused by the U.S. Securities and Exchange Commission of misleading investors about the Cambridge biotech's ultimately failed effort to secure FDA approval for a kidney cancer drug in 2012 and 2013.



from Biotech News
Share:

Finanzen: Kündigungsfristen im Arbeitsrecht : Kündigungsfristen für Arbeitnehmer und Arbeitgeber

Wenn Sie Ihren Job wechseln wollen, müssen Sie Ihre Kündigungsfrist beachten. Wonach sich diese richtet, lesen Sie in unserem Ratgeber.

from Finanztip Feed
Supported by Video Collection
Share:

Oncolytics Biotech, Inc. (ONCY) Expected to Post Earnings of -$0.19 Per Share

Oncolytics Biotech, Inc. (ONCY) Expected to Post Earnings of -$0.19 Per Share


Wall Street analysts expect that Oncolytics Biotech, Inc. will announce earnings per share for the current fiscal quarter, Zacks reports. Zero analysts have issued estimates for Oncolytics Biotech's earnings.



from Biotech News
Share:

South Cambs MP continues fight for cystic fibrosis drug at PMQs

South Cambs MP continues fight for cystic fibrosis drug at PMQs


The MP for South Cambridgeshire is continuing the fight for a cystic fibrosis drug to be made avilable on the NHS by raising the issue with Theresa May during Prime Minster's Question Time. Heidi Allen also met with Orkami manufacturer Vertex on Tuesday last week to discuss why the drug was stil not available on the NHS except in rare cases on compassionate grounds three years after the start of negotiations - even though the firm had received the largest ever offer made by NHS England.



from Biotech News
Share:

Researchers discover new biosynthetic pathway to antibiotics using gene editing

Researchers discover new biosynthetic pathway to antibiotics using gene editing


Scientists have discovered a new chemical process - also known as a biosynthetic pathway - in bacteria which could lead to a new generation of antibiotics being produced and manufactured. Researchers at The University of Manchester's School of Chemistry say their new pathway includes an enzyme, called a carboxylase, which adds CO2 to a precursor molecule producing a highly unusual antibiotic called malonomycin.



from Biotech News
Share:

Dispelling deadly myths about getting a u shot

Dispelling deadly myths about getting a u shot


Some people avoid getting the vaccine because they don't think it works well enough to be worth it. Some think they are too healthy to need it.



from Biotech News
Share:

Crossmark Global Holdings Inc. Has $14.50 Million Holdings in Amgen, Inc.

Crossmark Global Holdings Inc. Has $14.50 Million Holdings in Amgen, Inc.


Crossmark Global Holdings Inc. trimmed its position in shares of Amgen, Inc. by 7.1% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 69,926 shares of the medical research company's stock after selling 5,346 shares during the quarter.



from Biotech News
Share:

SPDR S&P Biotech Etf (Xbi) Position Trimmed by Nan Shan Life Insurance Co. Ltd.

SPDR S&P Biotech Etf (Xbi) Position Trimmed by Nan Shan Life Insurance Co. Ltd.


Nan Shan Life Insurance Co. Ltd. trimmed its holdings in shares of SPDR S&P Biotech ETF by 33.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission.



from Biotech News
Share:

Vir Biotechnology and Alnylam Pharmaceuticals Initiate Phase 1/2 Study of VIR-2218

Vir Biotechnology and Alnylam Pharmaceuticals Initiate Phase 1/2 Study of VIR-2218


SAN FRANCISCO & CAMBRIDGE, Mass.-- --Nov 26, 2018--Vir Biotechnology, Inc. and Alnylam Pharmaceuticals, Inc. today announced the initiation of a Phase 1/2 study of VIR-2218, a novel, investigational RNA interference therapeutic for the treatment of chronic hepatitis B virus infection. The commencement of first-in-human dosing marks the first clinical use of Alnylam's Enhanced Stabilization Chemistry-Plus GalNAc conjugate delivery platform and the start of Vir's first global development program.



from Biotech News
Share:

FTB Advisors Inc. Has $6.73 Million Stake in Amgen, Inc.

FTB Advisors Inc. Has $6.73 Million Stake in Amgen, Inc.


FTB Advisors Inc. decreased its stake in Amgen, Inc. by 2.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission . The institutional investor owned 32,464 shares of the medical research company's stock after selling 895 shares during the period.



from Biotech News
Share:

How many kids have autism? US government measures 3 ways

How many kids have autism? US government measures 3 ways


The Milestone Tracker phone app from the Centers for Disease Control and Prevention is displayed on Thursday, Nov. 22, 2018, in New York. The app was created to help parents recognize developmental delays.



from Biotech News
Share:

Zacks: Analysts Anticipate ImmunoGen, Inc. (IMGN) Will Announce Earnings of -$0.33 Per Share

Zacks: Analysts Anticipate ImmunoGen, Inc. (IMGN) Will Announce Earnings of -$0.33 Per Share


Wall Street analysts forecast that ImmunoGen, Inc. will announce earnings per share of for the current quarter, according to Zacks . Six analysts have provided estimates for ImmunoGen's earnings.



from Biotech News
Share:

CTI Industries (CTIB) versus Carlisle Companies (CSL) Financial Survey

CTI Industries (CTIB) versus Carlisle Companies (CSL) Financial Survey


Carlisle Companies and CTI Industries are both multi-sector conglomerates companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, profitability, risk and analyst recommendations. This is a summary of recent recommendations and price targets for Carlisle Companies and CTI Industries, as reported by MarketBeat.com.



from Biotech News
Share:

Biogen Inc (BIIB) Shares Bought by Westpac Banking Corp

Biogen Inc (BIIB) Shares Bought by Westpac Banking Corp


Westpac Banking Corp raised its position in shares of Biogen Inc by 230.9% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 62,442 shares of the biotechnology company's stock after acquiring an additional 43,570 shares during the period.



from Biotech News
Share:

Critical Contrast: Pharmacyte Biotech

Critical Contrast: Pharmacyte Biotech


Pharmacyte Biotech and FitLife Brands are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, dividends, institutional ownership, valuation and risk. Pharmacyte Biotech has a beta of 2.29, meaning that its share price is 129% more volatile than the S&P 500.



from Biotech News
Share:

#ImplantFiles: Faulty implants, basement surgeries, lives at risk

#ImplantFiles: Faulty implants, basement surgeries, lives at risk


The Indian Express joined around 100 other reporters from 36 countries for an ICIJ meeting in Washington DC to plan the most exhaustive health investigation ever mounted. More than half of the medical and diagnostic medical equipment used in private clinics and hospitals are imported as "pre-owned" or "second hand" with no assessments done on their levels of accuracy or safety.



from Biotech News
Share:

Gilead Sciences (GILD) Downgraded by ValuEngine to Sell

Gilead Sciences (GILD) Downgraded by ValuEngine to Sell


Other analysts also recently issued research reports about the stock. BidaskClub raised shares of Gilead Sciences from a hold rating to a buy rating in a research report on Thursday, October 11th.



from Biotech News
Share:

Illumina, Inc. (ILMN) Shares Sold by ELCO Management Co. LLC

Illumina, Inc. (ILMN) Shares Sold by ELCO Management Co. LLC


ELCO Management Co. LLC reduced its holdings in Illumina, Inc. by 2.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission .



from Biotech News
Share:

Fmr LLC Purchases 6,255,915 Shares of Eli Lilly And Co

Fmr LLC Purchases 6,255,915 Shares of Eli Lilly And Co


Fmr LLC boosted its position in Eli Lilly And Co by 526.5% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission . The fund owned 7,444,216 shares of the company's stock after buying an additional 6,255,915 shares during the quarter.



from Biotech News
Share:

Zacks: Brokerages Expect Agenus Inc (AGEN) Will Announce Quarterly Sales of $5.67 Million

Zacks: Brokerages Expect Agenus Inc (AGEN) Will Announce Quarterly Sales of $5.67 Million


Brokerages expect Agenus Inc to report sales of $5.67 million for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for Agenus' earnings, with estimates ranging from $5.00 million to $6.34 million.



from Biotech News
Share:

Trexquant Investment LP Grows Position in McKesson Co.

Trexquant Investment LP Grows Position in McKesson Co.


Trexquant Investment LP lifted its stake in shares of McKesson Co. by 259.9% during the third quarter, according to its most recent filing with the Securities & Exchange Commission.



from Biotech News
Share:

Victory Capital Management Inc. Acquires 28,199 Shares of Mylan NV

Victory Capital Management Inc. Acquires 28,199 Shares of Mylan NV


Victory Capital Management Inc. increased its holdings in shares of Mylan NV by 50.8% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 83,692 shares of the company's stock after acquiring an additional 28,199 shares during the period.



from Biotech News
Share:

Brokerages Anticipate Oncolytics Biotech, Inc. (ONCY) Will Post Earnings of -$0.19 Per Share

Brokerages Anticipate Oncolytics Biotech, Inc. (ONCY) Will Post Earnings of -$0.19 Per Share


Equities research analysts expect Oncolytics Biotech, Inc. to announce earnings of per share for the current fiscal quarter, Zacks reports. Zero analysts have made estimates for Oncolytics Biotech's earnings.



from Biotech News
Share:

Utah researchers get federal funds to study nonaddictive alternatives to opioids

Utah researchers get federal funds to study nonaddictive alternatives to opioids


University of Utah Health researchers will use $2.6 million from the National Institutes of Health to study new substances to see if they can be effective in treating pain without the addictive side effects of opioids. The funds, announced late last month, are to be used over the course of the year by University of Utah Health's College of Pharmacy, which will oversee the testing of "blinded samples of small compounds, natural products and biologics" sent out for testing by the National Institute of Neurological Disorders and Stroke, the university said in a release.



from Biotech News
Share:

Somewhat Positive Press Coverage Unlikely to Impact Novo Resources (NVO) Stock Price

Somewhat Positive Press Coverage Unlikely to Impact Novo Resources (NVO) Stock Price


News stories about Novo Resources have been trending somewhat positive recently, according to InfoTrie. The research group ranks the sentiment of press coverage by analyzing more than 6,000 blog and news sources in real time.



from Biotech News
Share:

Zacks: Analysts Expect Moleculin Biotech Inc (MBRX) Will Announce Earnings of -$0.14 Per Share

Zacks: Analysts Expect Moleculin Biotech Inc (MBRX) Will Announce Earnings of -$0.14 Per Share


Wall Street analysts expect that Moleculin Biotech Inc will post earnings per share for the current fiscal quarter, according to Zacks Investment Research . Zero analysts have provided estimates for Moleculin Biotech's earnings.



from Biotech News
Share:

Rising fear among Asians leads Eli Lilly to rethink employee groups

Rising fear among Asians leads Eli Lilly to rethink employee groups


As part of a job offer from Eli Lilly and Co., new employees get a letter encouraging them to join one of the pharmaceutical firm's affinity groups.



from Biotech News
Share:

Twin Capital Management Inc. Trims Stake in Amgen, Inc.

Twin Capital Management Inc. Trims Stake in Amgen, Inc.


Twin Capital Management Inc. reduced its position in shares of Amgen, Inc. by 1.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 98,270 shares of the medical research company's stock after selling 1,742 shares during the period.



from Biotech News
Share:

JPMorgan Chase & Co. Reaffirms Neutral Rating for GlaxoSmithKline

JPMorgan Chase & Co. Reaffirms Neutral Rating for GlaxoSmithKline


's stock had its "neutral" rating reissued by stock analysts at JPMorgan Chase & Co. in a note issued to investors on Friday.



from Biotech News
Share:

UK investigator targets Chinese television in Britain over aired confession

UK investigator targets Chinese television in Britain over aired confession


A private investigator previously jailed in China has asked Britain to restrict China Central Television's operations on the grounds that it broke UK broadcasting rules by airing confessions he said he was forced to make. Briton Peter Humphrey and his American wife Yu Yingzeng were sentenced in 2014 for illegally obtaining private records of Chinese citizens and selling the information to clients, including drugmaker GlaxoSmithKline.



from Biotech News
Share:

Athersys, Inc. (ATHX) Given Consensus Rating of "Strong Buy" by Brokerages

Athersys, Inc. (ATHX) Given Consensus Rating of "Strong Buy" by Brokerages


Athersys, Inc. has received an average broker rating score of 1.00 from the two brokers that provide coverage for the company, Zacks Investment Research reports. Two research analysts have rated the stock with a strong buy rating.



from Biotech News
Share:

Zacks: Analysts Anticipate Esperion Therapeutics Inc (ESPR) to Announce -$1.36 Earnings Per Share

Zacks: Analysts Anticipate Esperion Therapeutics Inc (ESPR) to Announce -$1.36 Earnings Per Share


Wall Street analysts predict that Esperion Therapeutics Inc will announce earnings of per share for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for Esperion Therapeutics' earnings.



from Biotech News
Share:

Finanzen: Amazon-Visa-Karte : Amazon Kreditkarte

Mit der Amazon-Kreditkarte sammeln Sie Punkte beim Bezahlen. Die können Sie wieder zum Einkaufen benutzen. Die Karte ist aber teuer.

from Finanztip Feed
Supported by Video Collection
Share:

Thomson Horstmann & Bryant Inc. Sells 5,601 Shares of Neogen Co.

Thomson Horstmann & Bryant Inc. Sells 5,601 Shares of Neogen Co.


Thomson Horstmann & Bryant Inc. cut its stake in Neogen Co. by 22.9% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission.



from Biotech News
Share:

Finanzen: Witwenrente : Witwenrente

Verstirbt der Ehepartner, hat der Hinterbliebene Anspruch auf eine Witwer- oder Witwenrente. Die beläuft sich auf 55 Prozent der Bezüge des Verstorbenen.

from Finanztip Feed
Supported by Video Collection
Share:

Novartis erhält EU-Zulassung für Gen-Therapie gegen vererbbaren Sehverlust

Novartis erhält EU-Zulassung für Gen-Therapie gegen vererbbaren Sehverlust


(dpa-AFX) Novartis darf die Gen-Therapie Luxturna in der EU auf den Markt bringen. Die EU-Kommission hat der Therapie für eine seltenen Form von vererbbarem Sehverlust die Zulassung erteilt, wie der schweizerische Konzern am Freitag in Basel mitteilte. Die Zulassung ist keine Überraschung, nachdem d...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Fmr LLC Has $2.93 Billion Position in Alexion Pharmaceuticals, Inc.

Fmr LLC Has $2.93 Billion Position in Alexion Pharmaceuticals, Inc.


Fmr LLC increased its holdings in Alexion Pharmaceuticals, Inc. by 8.1% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 21,096,993 shares of the biopharmaceutical company's stock after buying an additional 1,581,376 shares during the period.



from Biotech News
Share:

Novartis erhält EU-Zulassung für Gen-Therapie gegen vererbbarem Sehverlust

Novartis erhält EU-Zulassung für Gen-Therapie gegen vererbbarem Sehverlust


(dpa-AFX) Novartis darf die Gen-Therapie Luxturna in der EU auf den Markt bringen. Die EU-Kommission hat der Therapie für eine seltenen Form von vererbbarem Sehverlust die Zulassung erteilt, wie der schweizerische Konzern am Freitag in Basel mitteilte. Die Zulassung ist keine Überraschung, nachdem d...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Bahl & Gaynor Inc. Has $20.54 Million Position in Eli Lilly And Co

Bahl & Gaynor Inc. Has $20.54 Million Position in Eli Lilly And Co


Bahl & Gaynor Inc. boosted its holdings in Eli Lilly And Co by 576.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 191,400 shares of the company's stock after acquiring an additional 163,091 shares during the quarter.



from Biotech News
Share:

US appeals court declines J&J bid to stop generic Zytiga sales

US appeals court declines J&J bid to stop generic Zytiga sales


A U.S. appeals court on Wednesday declined a request by Johnson & Johnson for a temporary restraining order blocking sales of generic versions of its blockbuster prostate cancer drug Zytiga from hitting the U.S. market. REUTERS: A U.S. appeals court on Wednesday declined a request by Johnson & Johnson for a temporary restraining order blocking sales of generic versions of its blockbuster prostate cancer drug Zytiga from hitting the U.S. market.



from Biotech News
Share:

Gilead's CEO is leaving by the end of the year, and the biotech giant ...

Gilead's CEO is leaving by the end of the year, and the biotech giant ...


Gilead's CEO is leaving by the end of the year, and the biotech giant still hasn't picked a replacement. Wall Street has a few ideas.



from Biotech News
Share:

Suicide rate rising among U.S. workers

Suicide rate rising among U.S. workers


Suicide rates are rising among U.S. workers, and the risk may depend partly on the types of jobs people do, government researchers suggest. From 2000 to 2016, the U.S. suicide rate among adults ages 16 to 64 rose 34 percent, from 12.9 deaths for every 100,000 people in the population to 17.3 per 100,000, according to the study by the Centers for Disease Control and Prevention .



from Biotech News
Share:

Finanzen: KfW Einbruchschutz : Einbruchschutz (Kfw Förderung)

Wer Haus oder Wohnung besser gegen Einbruch schützt, kann dafür bei der KfW einen zinsgünstigen Kredit oder einen Zuschuss beantragen.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: KfW Umbauen : KfW 455

Wer altersgerecht umbaut, Barrieren reduziert und den Einbruchschutz verbessert, kann Förderung bei der KfW beantragen.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Steuertipps zum Jahresende : Steuertipps 2018

Paare, die noch bis Silvester heiraten, profitieren rückwirkend vom Ehegattensplitting. Wir verraten Ihnen außerdem weitere Steuervorteile zum Jahresende.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Heizöl kaufen : Heizöl kaufen

Im Internet können Sie ganz einfach die Preise für Heizöl vergleichen und beim günstigsten Händler bestellen.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: KfW Förderung : KfW Förderung - Bauförderung und Kredit

Die staatliche Förderbank KfW finanziert Haus oder Wohnung, das Studium oder die Existenzgründung. Verbraucher sollten die Möglichkeiten kennen

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: KfW energieeffizient sanieren : KfW 430

Wer Haus oder Wohnung energetisch saniert, sollte die Förderungen der KfW kennen. Es winken günstige Kredite und Zuschüsse.

from Finanztip Feed
Supported by Video Collection
Share:

Romaine lettuce swept off HK shelves amid E. coli poisoning in US

Romaine lettuce swept off HK shelves amid E. coli poisoning in US


Hong Kong has held romaine lettuce imported from the United States and Canada for tests amid outbreaks of E. coli poisoning in those countries.The vegetable will be allowed for sale after passing tests, according to the Centre for Food Safety. This comes after the Atlanta-based Centers for Disease Control and Prevention said 32 people were reported sick from E. coli poisoning in 11 states, with 13... Hong Kong has held romaine lettuce imported from the United States and Canada for tests amid outbreaks of E. coli poisoning in those countries.



from Biotech News
Share:

Finanzen: PKV-Beitrag senken : PKV Kosten senken

Wenn der Beitrag der privaten Krankenversicherung zu teuer ist, gibt es verschiedene Möglichkeiten, diesen zu senken.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Krankenversicherung der Energie-BKK : Energie-BKK Krankenversicherung

Die Energie-BKK bietet gute Zusatzleistungen in allen Bereichen. Der Beitrag entspricht dem Durchschnitt aller Krankenkassen.

from Finanztip Feed
Supported by Video Collection
Share:

Evotec und Immuneering setzen künstliche Intelligenz zur Liganden-Identifizierung ein

Evotec und Immuneering setzen künstliche Intelligenz zur Liganden-Identifizierung ein


Evotec AG gab den Beginn einer Forschungszusammenarbeit mit Immuneering Corporation bekannt. Ziel ist es, neue niedermolekulare Substanzen zur Behandlung seltener, erblicher Stoffwechselerkrankungen zu entdecken. Diese Partnerschaft kombiniert Evotecs induzierte pluripotente Stammzellplattform („iPS...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Suicide Rate Rising Among US Workers, CDC Study Finds

Suicide Rate Rising Among US Workers, CDC Study Finds


A young volunteer helps set up lights in paper bags decorated with messages for loved ones during an Out of the Darkness Walk event organized by the Cincinnati Chapter of the American Foundation for Suicide Prevention, Oct. 15, 2017, in Cincinnati. Suicide rates are rising among U.S. workers, and the risk may depend partly on the types of jobs people do, government researchers suggest.



from Biotech News
Share:

Automatisierte Optimierung und Synthese von Pharmaka per Cloud

Automatisierte Optimierung und Synthese von Pharmaka per Cloud


image description
Per Internet bestellen, Urlaubsfotos in einer Cloud speichern, den Thermostaten der Heizung per App von unterwegs hochdrehen – inzwischen weit verbreitet. Nun halten das Internet der Dinge und die Cloud Einzug in die Welt der chemischen Forschung und Produktion, wie Forscher in der Zeitschrift Angew...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Mehr industrielle Startups in den Städten

Mehr industrielle Startups in den Städten


image description
In den vergangenen Jahrzehnten ist die Industrie aus den Großstädten abgewandert. Durch die Digitalisierung könnte sich das nun ändern, auch in Städten wie Berlin. Allerdings sieht die Entwicklung in der Hauptstadt bei industriellen Startups derzeit besser aus als in vielen bestehenden Industrieunte...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Main Management LLC Has $14.65 Million Stake in SPDR S&P Biotech Etf

Main Management LLC Has $14.65 Million Stake in SPDR S&P Biotech Etf


Main Management LLC cut its position in SPDR S&P Biotech ETF by 5.6% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 152,783 shares of the exchange traded fund's stock after selling 9,069 shares during the quarter.



from Biotech News
Share:

Briefcase

Briefcase


LifePoint Health, Inc. has completed its merger with RCCH HealthCare Partners, which is owned by certain funds managed by affiliates of Apollo Global Management LLC. As a result of the merger, LifePoint's common stock is no longer trading on NASDAQ and will be delisted. The combined, privately held company will operate under the LifePoint Health name and includes a footprint of regional health systems, physician practices, outpatient centers, and post-acute facilities in more than 85 no-urban communities that span coast to coast.



from Biotech News
Share:

Judge Picks First Case for Trial in Federal Monsanto Weedkiller Litigation

Judge Picks First Case for Trial in Federal Monsanto Weedkiller Litigation


A U.S. judge overseeing the federal litigation against Bayer AG's Monsanto unit over glyphosate-based weed-killers allegedly causing cancer on Tuesday selected the first case to be tried in federal court in February 2019. U.S. District Judge Vince Chaabria in San Francisco in an order said the case of California resident Edwin Hardeman will be the first out of more than 620 cases pending in the federal litigation to go to a jury.



from Biotech News
Share:

Investment Analysts' Weekly Ratings Updates for Eli Lilly And Co

Investment Analysts' Weekly Ratings Updates for Eli Lilly And Co


11/7/2018 - Eli Lilly And Co was given a new $106.00 price target on by analysts at Societe Generale. They now have a "hold" rating on the stock.



from Biotech News
Share:

Romaine lettuce is not safe to eat, CDC warns US consumers

Romaine lettuce is not safe to eat, CDC warns US consumers


Romaine lettuce is unsafe to eat in any form, the Centers for Disease Control and Prevention said Tuesday in a broad alert in response to a new outbreak of illnesses caused by a particularly dangerous type of E. coli contamination. less Romaine lettuce is unsafe to eat in any form, the Centers for Disease Control and Prevention said Tuesday in a broad alert in response to a new outbreak of illnesses caused by a particularly dangerous type of ... more Romaine lettuce is unsafe to eat in any form, the Centers for Disease Control and Prevention said Tuesday in a broad alert in response to a new outbreak of illnesses caused by a particularly dangerous type of E. coli contamination.



from Biotech News
Share:

Finanzen: LTE : LTE

LTE macht das Surfen unterwegs und zu Hause schneller. Doch nicht jeder kann den schnellen Datenfunk sofort nutzen.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: O2-Netz : O2 Telefónica-Netz

Handytarife im O2-Netz sind günstig. Doch nicht für alle Kunden reicht die O2-Netzabdeckung. So prüfen Sie die Netzqualität.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: D2-Netz : D2 Vodafone-Netz

Viele Handytarife im D2-Netz bieten ein gutes Preis-Leistungs-Verhältnis. Das Handynetz von Vodafone hat kaum Schwächen – und eine große Stärke.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: D1-Netz : D1 Telekom-Netz

Handytarife im Netz der Deutschen Telekom sind teuer, bieten aber auch eine gute Netzqualität.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Netz-Vergleich : Netzabdeckung Deutschland

Die Wahl des passenden Mobilfunknetzes ist wichtig, wenn Kunden einen neuen Handyvertrag abschließen. Wir zeigen die Unterschiede.

from Finanztip Feed
Supported by Video Collection
Share:

Millions left behind as diabetes drives surge in insulin demand

Millions left behind as diabetes drives surge in insulin demand


FILE PHOTO: An employee walks in the insulin production plant of Danish multinational pharmaceutical company Novo Nordisk in Chartres, north-central France, April 21, 2016. REUTERS/Guillaume Souvant/Pool/File Photo LONDON: A global diabetes epidemic is fuelling record demand for insulin but tens of millions will not get the injections they need unless there is a dramatic improvement in access and affordability, a new study concluded on Wednesday Diabetes - which can lead to blindness, kidney failure, heart problems, neuropathic pain and amputations - now affects 9 per cent of all adults worldwide, up from 5 per cent in 1980.



from Biotech News
Share:

Besseres Datenmanagement im Kampf gegen Krebs

Besseres Datenmanagement im Kampf gegen Krebs


Merck und das Software-Unternehmen Palantir Technologies beabsichtigen, ein Joint Venture mit dem Markennamen Syntropy zu gründen. Syntropy soll Wissenschaftlern und Forschungszentren den Zugang zu einer kollaborativen Technologieplattform ermöglichen, um die Krebsforschung voranzutreiben, den wisse...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Mangel an Grippe-Impfstoff in vielen Teilen Deutschlands

Mangel an Grippe-Impfstoff in vielen Teilen Deutschlands


image description
(dpa) Grippe-Impfstoffe werden in vielen Teilen Deutschlands knapp. «Alles, was jetzt kommt, wird nicht mehr geimpft», sagte etwa der Geschäftsführer der Apothekenkammer des Saarlandes, Carsten Wohlfeil. «Bei allen Lieferanten ist momentan nichts zu holen», erklärte Stefan Fink, Vorsitzender des Thü...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Romaine lettuce not safe to eat: CDC, FDA issue warnings ahead of Thanksgiving

Romaine lettuce not safe to eat: CDC, FDA issue warnings ahead of Thanksgiving


The Centers for Disease Control and Prevention has issued a food safety alert days before Thanksgiving as there has been a multistate outbreak of E. coli linked to romaine lettuce. An investigation by the CDC, the U.S. Food and Drug Administration and public health and regulatory officials in several states and Canada found that the infections may be linked to the lettuce.



from Biotech News
Share:

"Druggable" Krebsziel, das in einem Signalweg zur Regulierung der Organgröße gefunden wurde

"Druggable" Krebsziel, das in einem Signalweg zur Regulierung der Organgröße gefunden wurde


image description
Es ist bekannt, dass Krebs ungehindertes Zellwachstum bedeutet und dass ein biologischer Weg, der die Größe der Organe reguliert, der auf dem Hippo-Signalweg bekannt ist, auch an Krebs beteiligt ist. Es ist weiter bekannt, dass ein wichtiger Akteur auf diesem Weg, YAP, viele Arten von Tumoren anregt...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Die süße Seite der Fortpflanzungsbiologie

Die süße Seite der Fortpflanzungsbiologie


image description
Gegenwärtig steht Zucker unter Generalverdacht, für viele Volkskrankheiten und gesundheitliche Probleme der Menschheit, insbesondere in den Industrienationen, verantwortlich zu sein. Hierbei handelt es sich meist um Zucker, die aus Glucose oder Fructose aufgebaut sind, wie unser Haushaltszucker die ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Korean regulator eases up on biotech accounting issues

Korean regulator eases up on biotech accounting issues


South Korea's financial regulator said today it will give biotechnology and pharmaceutical firms leeway on listing rules, after allowing them to voluntarily restate accounting errors. Choi Jong Ku, chairman of the Financial Services Commission, said promising biotechnology and pharmaceutical firms will not be designated by the Korea Exchange as an "administrative issue" even if the... South Korea's financial regulator said today it will give biotechnology and pharmaceutical firms leeway on listing rules, after allowing them to voluntarily restate accounting errors.



from Biotech News
Share:

Woman says flu shot sent husband to ICU

Woman says flu shot sent husband to ICU


A Las Vegas woman tells 13 Action News the flu shot sent her husband to the ICU. Mahsa Saeidi reports.



from Biotech News
Share:

US court allows generic version of Indivior opioid abuse drug

US court allows generic version of Indivior opioid abuse drug


REUTERS: A U.S. appeals court on Tuesday allowed generic drug company Dr. Reddy's Laboratories to sell a copycat version of the Indivior Plc opioid treatment Suboxone Film, sending Indivior's stock price down more than 40 percent. The U.S. Court of Appeals for the Federal Circuit lifted a preliminary injunction that blocked Dr. Reddy's from selling the generic, saying a lower court judge erred in granting the request.



from Biotech News
Share:

CDC sets up task force as polio-like condition spreads

CDC sets up task force as polio-like condition spreads


The U.S. Centers for Disease Control and Prevention said on Monday it has established a task force to assist in an ongoing investigation into a rare condition that affects the nervous system and which has been detected in over 100 people this year.



from Biotech News
Share:

Pfizer Shares Rise Even as U.S. Lawmakers, Administration Criticize Drug Pricing

Pfizer Shares Rise Even as U.S. Lawmakers, Administration Criticize Drug Pricing


President Trump may not have tweeted at Pfizer yet, but that doesn't mean that government voices have been quiet on drug pricing. Shares of the New York City-based pharmaceutical giant are rising on Monday, shaking free of concerns over drug price raising and marching back toward "business as normal."



from Biotech News
Share:

Federal District Court Reduces Punitive Damages To Amount Of...

Federal District Court Reduces Punitive Damages To Amount Of...


Usually, when a defendant gets a punitive award reduced to the same amount as the compensatory damages, it considers that a victory. But while such a reduction recently saved Johnson & Johnson $15 million, I don't think that it should be satisfied with the result.



from Biotech News
Share:

Accelerating Health Care Innovation by Connecting Engineering and Medicine

Accelerating Health Care Innovation by Connecting Engineering and Medicine


Artificial heart valves, prosthetic hips, bedside monitors, MRI machines - these and so many other innovations that we now take for granted emerged at the interface of engineering and medicine. In an era of big data, personalized medicine and artificial intelligence, the importance of engineering, especially in medicine, is increasing.



from Biotech News
Share:

Pfizer raising drug prices in 2019

Pfizer raising drug prices in 2019


Months after it agreed to hold off raising prices following heavy pressure from President Donald Trump, Pfizer said it will increase the prices of 41 drugs in January. The pharmaceutical giant says one drug will go up by 9 percent.



from Biotech News
Share:

Skorpiongift bringt Medikamente ins Gehirn

Skorpiongift bringt Medikamente ins Gehirn


image description
Das Labor für Peptide und Proteine am Institut für Biomedizinische Forschung (IRB Barcelona) beschreibt die Fähigkeit eines kleinen, aus Chlorotoxin gewonnenen Proteins (ein Peptid), das im Skorpiongift (Giant Yellow Israeli Scorpion) vorkommt, Medikamente über die Blut-Hirn-Schranke (BBB) zu transp...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Hartline Investment Corp Boosts Stake in SPDR S&P Biotech Etf

Hartline Investment Corp Boosts Stake in SPDR S&P Biotech Etf


Hartline Investment Corp lifted its holdings in SPDR S&P Biotech ETF by 26.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 38,227 shares of the exchange traded fund's stock after buying an additional 7,901 shares during the period.



from Biotech News
Share:

Baumwollbasierte Hybrid-Biokraftstoffzelle könnte implantierbare medizinische Geräte antreiben

Baumwollbasierte Hybrid-Biokraftstoffzelle könnte implantierbare medizinische Geräte antreiben


image description
Eine glukosebetriebene Biokraftstoffzelle, die Elektroden aus Baumwollfasern verwendet, könnte eines Tages helfen, implantierbare medizinische Geräte wie Herzschrittmacher und Sensoren zu betreiben. Die neue Brennstoffzelle, die doppelt so viel Strom liefert wie herkömmliche Biokraftstoffzellen, kön...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Skorpiongift, um Medikamente ins Gehirn zu bringen

Skorpiongift, um Medikamente ins Gehirn zu bringen


image description
Das Labor für Peptide und Proteine am Institut für Biomedizinische Forschung (IRB Barcelona) beschreibt die Fähigkeit eines kleinen, aus Chlorotoxin gewonnenen Proteins (ein Peptid), das im Skorpiongift (Giant Yellow Israeli Scorpion) vorkommt, Medikamente über die Blut-Hirn-Schranke (BBB) zu transp...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Zacks: Analysts Expect Oncolytics Biotech, Inc. (ONCY) Will Post Earnings of -$0.19 Per Share

Zacks: Analysts Expect Oncolytics Biotech, Inc. (ONCY) Will Post Earnings of -$0.19 Per Share


Wall Street brokerages expect that Oncolytics Biotech, Inc. will announce earnings per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Oncolytics Biotech's earnings.



from Biotech News
Share:

Merck KGaA (MRK) Given a 108.00 Price Target by Kepler Capital Markets Analysts

Merck KGaA (MRK) Given a 108.00 Price Target by Kepler Capital Markets Analysts


The brokerage currently has a buy rating on the healthcare company's stock. A number of other equities analysts also recently weighed in on the stock.



from Biotech News
Share:

Quidel (QDEL) - Analysts' Weekly Ratings Changes

Quidel (QDEL) - Analysts' Weekly Ratings Changes


Several brokerages have updated their recommendations and price targets on shares of Quidel in the last few weeks: 11/14/2018 - Quidel was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $76.00 price target on the stock.



from Biotech News
Share:

Finanzen: Außergewöhnliche Belastungen absetzen : Außergewöhnliche Belastungen

Krankheitskosten und Unterhaltsleistungen können von der Steuer abgesetzt werden – als außergewöhnliche Belastungen. Sofern sie einen Grenzwert überschreiten.

from Finanztip Feed
Supported by Video Collection
Share:

Charlottetown-based BioVectra named Canada's biotech company of the year

Charlottetown-based BioVectra named Canada's biotech company of the year


P.E.I. BioAlliance executive director Rory Francis, left, congratulates BioVectra president Oliver Technow during a ceremony Wednesday after the company received the BIOTECanada Gold Leaf Award for Company of the Year. - Terrence McEachern While holding the award for Canada's biotech company of the year, BioVectra president Oliver Technow reminded his staff that the award was not for the company but rather for them.



from Biotech News
Share:

Winton Group Ltd Has $549,000 Holdings in Immunomedics, Inc.

Winton Group Ltd Has $549,000 Holdings in Immunomedics, Inc.


WINTON GROUP Ltd grew its position in shares of Immunomedics, Inc. by 53.1% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 26,351 shares of the biopharmaceutical company's stock after purchasing an additional 9,137 shares during the quarter.



from Biotech News
Share:

Strengere Regeln als Konsequenz aus Medikamenten-Skandalen

Strengere Regeln als Konsequenz aus Medikamenten-Skandalen


(dpa) Als Konsequenz aus Pharmaskandalen um gestohlene und gepanschte Arzneimittel will sich der Bund stärker in die Überwachung einschalten und Marktregeln verschärfen. «Patienten müssen sich darauf verlassen können, dass Medikamente heilen und ihnen nicht schaden», sagte Gesundheitsminister Jens S...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Astrazeneca erleidet Schlappe bei Krebsmittel Imfinzi

Astrazeneca erleidet Schlappe bei Krebsmittel Imfinzi


(dpa-AFX) Der Pharmakonzern Astrazeneca muss einen Rückschlag bei seinem Krebsmittel Imfinzi einstecken. Das Mittel habe den primären Endpunkt einer abschließenden klinischen Studie (Phase-III) nicht erreicht, teilte der Konzern am Freitag in London mit. In dieser wurde der Einsatz des Mittels bei P...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Victory Capital Management Inc. Has $16.02 Million Position in Johnson & Johnson

Victory Capital Management Inc. Has $16.02 Million Position in Johnson & Johnson


Victory Capital Management Inc. decreased its position in shares of Johnson & Johnson by 45.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission . The firm owned 131,981 shares of the company's stock after selling 110,280 shares during the period.



from Biotech News
Share:

Commonwealth of Pennsylvania Public School Empls Retrmt SYS Sells...

Commonwealth of Pennsylvania Public School Empls Retrmt SYS Sells...


Commonwealth of Pennsylvania Public School Empls Retrmt SYS lowered its position in shares of Gilead Sciences, Inc. by 21.8% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 106,379 shares of the biopharmaceutical company's stock after selling 29,734 shares during the period.



from Biotech News
Share:

Oppenheimer Asset Management Inc. Has $15.71 Million Holdings in Pfizer Inc.

Oppenheimer Asset Management Inc. Has $15.71 Million Holdings in Pfizer Inc.


Oppenheimer Asset Management Inc. lowered its position in shares of Pfizer Inc. by 37.5% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 432,998 shares of the biopharmaceutical company's stock after selling 259,686 shares during the quarter.



from Biotech News
Share:

Great West Life Assurance Co. Can Acquires 403,854 Shares of Pfizer Inc.

Great West Life Assurance Co. Can Acquires 403,854 Shares of Pfizer Inc.


Great West Life Assurance Co. Can grew its holdings in Pfizer Inc. by 4.9% in the second quarter, according to the company in its most recent 13F filing with the SEC.



from Biotech News
Share:

Cardinal Health (CAH) Earns Daily News Sentiment Rating of 2.33

Cardinal Health (CAH) Earns Daily News Sentiment Rating of 2.33


News stories about Cardinal Health have trended positive on Saturday, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time.



from Biotech News
Share:

Croda Dives Deep into Sustainability with Marine Biotech Center Opening

Croda Dives Deep into Sustainability with Marine Biotech Center Opening


The ribbon-cutting celebration, held at the Regis and Joan Duffy Research Center at the University of PEI, included senior reps from Croda, UPEI, PEI's bioscience business and research community, and other key partners. Croda International celebrated the official opening of its Center of Innovation for Marine Biotechnology.



from Biotech News
Share:

South Texas Money Management Ltd. Has $61.75 Million Stake in Edwards Lifesciences Corp

South Texas Money Management Ltd. Has $61.75 Million Stake in Edwards Lifesciences Corp


South Texas Money Management Ltd. reduced its position in shares of Edwards Lifesciences Corp by 0.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission . The institutional investor owned 354,702 shares of the medical research company's stock after selling 3,227 shares during the period.



from Biotech News
Share:

School with major chickenpox outbreak has high vaccination exemption rate

School with major chickenpox outbreak has high vaccination exemption rate


A chickenpox outbreak at a private school now ranks as North Carolina's largest since a vaccine for the virus became available more than 20 years ago, health officials say. As of Friday, 36 students at Asheville Waldorf School had contracted the varicella virus , known to most as chickenpox.



from Biotech News
Share:

Nomura Asset Management Co. Ltd. Sells 3,694 Shares of AmerisourceBergen Corp.

Nomura Asset Management Co. Ltd. Sells 3,694 Shares of AmerisourceBergen Corp.


Nomura Asset Management Co. Ltd. trimmed its position in shares of AmerisourceBergen Corp. by 3.8% during the third quarter, according to its most recent Form 13F filing with the SEC.



from Biotech News
Share:

Bristol-Myers Squibb Co (BMY) is Doyle Wealth Management's 8th Largest Position

Bristol-Myers Squibb Co (BMY) is Doyle Wealth Management's 8th Largest Position


Doyle Wealth Management raised its position in Bristol-Myers Squibb Co by 3.6% during the third quarter, according to its most recent 13F filing with the SEC. The fund owned 308,942 shares of the biopharmaceutical company's stock after buying an additional 10,743 shares during the period.



from Biotech News
Share:

Odisha launches Biotechnology Policy 2018

Odisha launches Biotechnology Policy 2018


Bhubaneswar, Nov 15 : Odisha on Thursday launched a Biotechnology Policy 2018 with the aim of providing attractive incentives to stakeholders to invest in the state. "We assure investors full support of the state government for the whole life cycle of the project.



from Biotech News
Share:

Calif. Jury Hands J&J Defense Verdict in Talc Case, While S.C. Matter Ends in Mistrial

Calif. Jury Hands J&J Defense Verdict in Talc Case, While S.C. Matter Ends in Mistrial


In California, a jury rendered a defense verdict, giving Johnson & Johnson the upper hand in the litigation alleging its asbestos-containing talcum powder products caused mesothelioma, a deadly form of lung cancer. Until then, there were eight previous trials.



from Biotech News
Share:

NanoSphere Announces $2.25 Million Financing for Rapid Expansion of Cannabis Product Line

NanoSphere Announces $2.25 Million Financing for Rapid Expansion of Cannabis Product Line


The proceeds will be used to expand the award-winning Evolve Formulas cannabis products into more markets in the US, Canada, and outside of North America. Funds will also be used to develop new products, increase production in the states that Evolve Products are available in, as well as for general working capital.



from Biotech News
Share:

A nurse administers a flu shot at Perry Memorial Hospital in Princeton, Illinois, on Oct. 12, 2017.

A nurse administers a flu shot at Perry Memorial Hospital in Princeton, Illinois, on Oct. 12, 2017.


Crafting better flu shots comes down to dispensing with 1940s technology, according to CSL Ltd., which says its new method of vaccine production may offer better protection against the virus that killed almost 200 American children last season. Flucelvax, an immunization produced by CSL's Seqirus unit with cell-based technology, was 36.2 percent more effective in preventing flu-like illness last winter than conventional shots made using chicken eggs, the Melbourne-based company said in a study released Friday.



from Biotech News
Share:

Pfizer to raise drug prices in January; says insurance can offset the cost

Pfizer to raise drug prices in January; says insurance can offset the cost


Pfizer said Friday that it will be raising the prices of 41 drugs, or 10 percent of its product portfolio, in January. The pharmacy giant indicated in a release that the increase for most of the affected drugs would be 5 percent, though three products will see a 3 percent rise, and one will climb 9 percent due "to the completion of two extensive development programs that have led to the recent FDA approvals of two new medical uses that meet unmet patient needs."



from Biotech News
Share:

Research Analysts' Upgrades for November, 16th (ABC, CUB,...

Research Analysts' Upgrades for November, 16th (ABC, CUB,...


According to Zacks, "AmerisourceBergen exited the fiscal fourth quarter on a tepid note. While earnings edged past the consensus mark, revenues lagged the same.



from Biotech News
Share:

Eli Lilly And Co (LLY) Stake Lowered by Piedmont Investment Advisors Inc.

Eli Lilly And Co (LLY) Stake Lowered by Piedmont Investment Advisors Inc.


Piedmont Investment Advisors Inc. decreased its position in shares of Eli Lilly And Co by 3.7% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 162,904 shares of the company's stock after selling 6,319 shares during the quarter.



from Biotech News
Share:

DHEC confirms another case of polio-like illness in SC

DHEC confirms another case of polio-like illness in SC


This 2014 electron microscope image made available by the Centers for Disease Control and Prevention shows numerous, spheroid-shaped Enterovirus-D68 virions. Doctors have suspected a mysterious paralyzing illness, acute flaccid myelitis, might be tied to a kind of enterovirus, such as EV-D68 or EV-A71.



from Biotech News
Share:

Jennie-O Turkey Store Sales, LLC Recalls Raw Ground Turkey Products...

Jennie-O Turkey Store Sales, LLC Recalls Raw Ground Turkey Products...


EDITOR'S NOTE: FSIS and our public health partners, including the Centers for Disease Control and Prevention and state public health officials, are investigating a Salmonella Reading outbreak . Please note that FSIS is continuing to investigate illnesses associated with this widespread outbreak, and additional product from other companies may also be recalled.



from Biotech News
Share:

California judge orders next Monsanto weed-killer cancer trial for March

California judge orders next Monsanto weed-killer cancer trial for March


A California judge on Thursday granted an expedited trial in the case of a California couple suffering from cancer who sued Bayer AG's Monsanto unit, alleging the company's glyphosate-containing weed killer Roundup caused their disease.



from Biotech News
Share:

Nursing home bacteria investigated

Nursing home bacteria investigated


The Vermont Department of Health and officials from the Centers for Disease Control and Prevention are working with the Wake Robin retirement community in Shelburne to respond to an outbreak of extensively drug resistant "Shigella sonnei" infections. Shigella is a type of bacteria that can make people sick with diarrhea, stomach cramps, and sometimes a fever.



from Biotech News
Share:

Novartis-Sprecher: Keine Abspaltung von Generikasparte Sandoz

Novartis-Sprecher: Keine Abspaltung von Generikasparte Sandoz


(dpa-AFX) Novartis will seine Nachahmersparte Sandoz entgegen anderslautender Medienberichte nicht abspalten. Der Konzern erwäge einen solchen Schritt nicht, sagte ein Sprecher am Donnerstag auf Anfrage der Nachrichtenagentur Bloomberg. "Wir haben über einen Umbau gesprochen, nicht über eine Abspalt...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

The Daily Biotech Pulse: FDA Nod For Mallinckrodt's Pain Drug,...

The Daily Biotech Pulse: FDA Nod For Mallinckrodt's Pain Drug,...


AbbVie Inc and Neurocrine Biosciences, Inc. presented positive additional results from two replicate Phase 3 trials that evaluated the efficacy and safety of elagolix in women with uterine fibroids at the 47th American Association of Gynecologic Laparoscopists Global Congress on Minimally Invasive Gynecology in Las Vegas, Nevada. At month six of the six-month treatment period, elagolix 300mg twice a day in combination with low-dose hormone therapy reduced heavy menstrual bleeding related to uterine fibroids compared to placebo.



from Biotech News
Share:

United Therapeutics to develop, sell Arena Pharma's hypertension treatment

United Therapeutics to develop, sell Arena Pharma's hypertension treatment


United Therapeutics Corp on Thursday signed a deal potentially worth up to $1.2 billion for the rights to develop and sell Arena Pharmaceuticals Inc's pulmonary arterial hypertension treatment . The two companies said the deal for Arena's late-stage experimental treatment, ralinepag, includes milestone payments of up to $400 million based on certain regulatory events in addition to an upfront payment of $800 million.



from Biotech News
Share:

Jury clears J&J of liability in California talc cancer case

Jury clears J&J of liability in California talc cancer case


A California jury on Wednesday cleared Johnson & Johnson of liability in a case involving a woman who alleged that the company's talc-based products, including its baby powder, contain asbestos and caused her cancer, the company said. FILE PHOTO: Bottles of Johnson & Johnson baby powder line a drugstore shelf in New York October 15, 2015.



from Biotech News
Share:

US officials report a record number of tick diseases

US officials report a record number of tick diseases


This March 2002 file photo shows a deer tick under a microscope in the entomology lab at the University of Rhode Island in South Kingstown, R.I. On Wednesday, Nov. 14, 2018, the Centers for Disease Control and Prevention said a record number of tick-borne diseases _ more than 59,000 _ were reported in 2017. It's a 22 percent increase from the number reported the year before.



from Biotech News
Share:

Imperial Beach, Scripps Institution collaborate to tackle sea-level rise

Imperial Beach, Scripps Institution collaborate to tackle sea-level rise


The City of Imperial Beach and the Scripps Institution of Oceanography announced the details Wednesday of the city's plan for dealing with rising sea levels. An April 2017 report by the California Ocean Protection Council found that sea levels in La Jolla could rise between two and 10 feet by the end of the century.



from Biotech News
Share:

The Time Could Be Right For This Biotech ETF

The Time Could Be Right For This Biotech ETF


Biotechnology stocks and exchange traded funds have been slumping since last week's midterm elections and that could be an ominous sign. On Monday, the S&P Biotechnology Select Industry Index fell 3.59 percent on volume that was well above the daily average, extending what are becoming significant monthly and quarterly losses.



from Biotech News
Share:

Novartis will sich offenbar komplett von Sandoz trennen

Novartis will sich offenbar komplett von Sandoz trennen


(dpa-AFX) Bei Novartis geht das Großreinemachen offenbar weiter: Laut einem Bericht des "Tagesanzeigers" plant der Konzern nun auch noch die Abspaltung der Generikasparte Sandoz. Das habe Konzernchef Vas Narasimhan an einem Investorentreffen vergangene Woche gesagt. Erst im Sommer hatte Novartis den...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Cutting-edge biotech Sangamo stock dives 13% after JPMorgan cites...

Cutting-edge biotech Sangamo stock dives 13% after JPMorgan cites...


Its technology uses proteins called zinc finger nucleases to edit human genes, with the hope that just one procedure could improve patients' lives, and even offer a genetic cure. is developing programs for a range of devastating diseases, and has valuable deals with prominent pharmaceutical companies like Gilead Sciences Inc. Not enough, apparently, for Sangamo to retain its "overweight" rating at JPMorgan, with analyst Eric Joseph downgrading the company to "neutral" early Wednesday and slashing the company's price target by nearly 70%, to $11.



from Biotech News
Share:

Progress in Food Biotechnology

Progress in Food Biotechnology


This volume is a handy resource for a broad range of industrial researchers, students, and biotech professionals from both academia and industry who are involved in the multidisciplinary fields of food biotechnology and food chemistry.



from Biotech News
Share:

Motten und Magnete könnten Leben retten

Motten und Magnete könnten Leben retten


image description
Eine neue Technologie, die auf einem motteninfizierenden Virus und Nanomagneten basiert, könnte verwendet werden, um defekte Gene zu bearbeiten, die zu Krankheiten wie Sichelzellenanämie, Muskeldystrophie und Mukoviszidose führen.Der Bioingenieur der Rice University, Gang Bao, hat magnetische Nanopa...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

"Walzer-Nanopartikel" könnten die Suche nach besseren Drug Delivery-Methoden vorantreiben

"Walzer-Nanopartikel" könnten die Suche nach besseren Drug Delivery-Methoden vorantreiben


image description
Forscher der Indiana University haben entdeckt, dass sich wirkstoffabgebende Nanopartikel an ihren Zielen unterschiedlich anlagern, je nach ihrer Position, an der sie sich treffen - wie Ballsaaltänzer, die ihre Bewegungen mit der Musik ändern.Die Studie ist signifikant, da die "Bewegung" von therape...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Grünenthal erwirbt Averitas Pharma und baut kommerzielle Präsenz in den USA auf

Grünenthal erwirbt Averitas Pharma und baut kommerzielle Präsenz in den USA auf


Grünenthal gab bekannt, dass es das amerikanische Pharmaunternehmen Averitas Pharma erworben hat und damit seine kommerzielle Präsenz auf die USA ausweitet. Averitas Pharma wird die Vermarktung des Schmerzpflasters Qutenza® (8 % capsaicin) für Grünenthal in den USA übernehmen. Grünenthal hatte erst ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Pfizer loses blockbuster drug patent fight in UK Supreme Court

Pfizer loses blockbuster drug patent fight in UK Supreme Court


Pfizer lost the final round in a long-running patent battle in Britain on Wednesday after the country's highest court ruled against it in a case involving its $5 billion-a-year pain drug Lyrica. FILE PHOTO: A logo of American pharmaceutical corporation Pfizer Inc., is pictured in Toluca, Mexico October 1, 2018.



from Biotech News
Share:

Third Flu Death Of 2018 Reported In Arkansas

Third Flu Death Of 2018 Reported In Arkansas


The department's weekly flu report noted that the state has reported "sporadic" activity to the Centers for Disease Control and Prevention for a geographic spread and a "minimal" level of intensity. ADH has received more than 700 positive flu tests since Sept.



from Biotech News
Share:

Roivant Sciences climbs to $7 billion valuation

Roivant Sciences climbs to $7 billion valuation


Roivant Sciences has raised $200 million in a new funding round that makes it one of the most highly valued private firms in the history of the biotechnology industry at $7 billion, according to the company. Previous backers, including SoftBank's Vision Fund took part in the new financing, as did new investors NovaQuest Capital Management and RTW Investments, Roivant said Tuesday.



from Biotech News
Share:

Novartis konkretisiert Pläne für Abspaltung der Augensparte Alcon

Novartis konkretisiert Pläne für Abspaltung der Augensparte Alcon


(dpa-AFX) Der schweizerische Pharmakonzern Novartis treibt seine Pläne zur geplanten Abspaltung der Augenheilsparte Alcon voran. Das notwendige Formular dazu wurde bei der amerikanischen Börsenaufsicht SEC eingereicht, wie Novartis am Dienstagabend mitteilte. Novartis hatte die Pläne zur Verselbstän...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

More US kids get paralyzing illness, cause is still unknown

More US kids get paralyzing illness, cause is still unknown


More children have been diagnosed with a mysterious paralyzing illness, and U.S. health officials still aren't sure what's causing it. . This 2014 electron microscope image made available by the Centers for Disease Control and Prevention shows numerous, spheroid-shaped Enterovirus-D68 virions.



from Biotech News
Share:

Express Scripts offers new formulary for lower list-price drugs

Express Scripts offers new formulary for lower list-price drugs


REUTERS: Express Scripts Holding Co on Tuesday announced a new drug reimbursement list with lower U.S. prices for brand-name medications, as a way to encourage drugmakers to move away from paying rebates after a prescription is filled. The manager of prescription drug benefits for large corporate employers and government health plans said its new National Preferred Flex Formulary will be available as of Jan. 1 to all clients.



from Biotech News
Share:

Stada nun fast vollständig in Hand der Finanzinvestoren

Stada nun fast vollständig in Hand der Finanzinvestoren


(dpa) Mehr als ein Jahr nach der Übernahme befindet sich der Pharmakonzern Stada nahezu komplett in Hand der Finanzinvestoren Bain und Cinven. Mit ihrem jüngsten Angebot haben sie fast alle übrigen Aktionäre des Grippostad-Herstellers überzeugt, wie sie am Dienstag in Frankfurt mitteilten. Bis zur F...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Oncolytics Biotech (ONCY) Posts Earnings Results, Beats Estimates By $0.04 EPS

Oncolytics Biotech (ONCY) Posts Earnings Results, Beats Estimates By $0.04 EPS


Oncolytics Biotech posted its quarterly earnings data on Monday. The company reported EPS for the quarter, topping analysts' consensus estimates of by $0.04, MarketWatch Earnings reports.



from Biotech News
Share:

Critical Analysis: Pacific Biosciences of California

Critical Analysis: Pacific Biosciences of California


Pacific Biosciences of California and Pressure Biosciences are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, dividends and analyst recommendations. This is a breakdown of recent recommendations and price targets for Pacific Biosciences of California and Pressure Biosciences, as provided by MarketBeat.com.



from Biotech News
Share:

Simon Dingemans Buys 8 Shares of GlaxoSmithKline plc (GSK) Stock

Simon Dingemans Buys 8 Shares of GlaxoSmithKline plc (GSK) Stock


GlaxoSmithKline plc insider Simon Dingemans bought 8 shares of the business's stock in a transaction that occurred on Friday, November 9th. The stock was acquired at an average cost of GBX 1,561 per share, for a total transaction of 124.88 .



from Biotech News
Share:

Eli Lilly And Co (LLY) Shares Bought by Robeco Institutional Asset Management B.V.

Eli Lilly And Co (LLY) Shares Bought by Robeco Institutional Asset Management B.V.


Robeco Institutional Asset Management B.V. increased its position in Eli Lilly And Co by 16.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission . The firm owned 508,814 shares of the company's stock after acquiring an additional 70,589 shares during the period.



from Biotech News
Share:

Noch mehr Glyphosat-Klagen gegen Bayer

Noch mehr Glyphosat-Klagen gegen Bayer


(dpa-AFX) Zuwächse im Pharmageschäft sowie bei Mais- und Sojasaat haben Bayer im dritten Quartal Rückenwind verliehen. Dem gegenüber standen Belastungen durch ungünstige Wechselkursentwicklungen etwa durch die Schwäche des brasilianischen Real. Der bereinigte operative Gewinn lag letztendlich über d...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

How To Trade Four 'Dogs Of The Dow' That Set New Highs

How To Trade Four 'Dogs Of The Dow' That Set New Highs


The Dow Jones Industrial Average ended last week at 25,989.30, up 5.1% year-to-date after setting its all-time intraday high of 26,951.81 on October 3. My weekly and monthly value levels are 25,483 and 24,976 with my annual and semiannual pivots of 24,666 and 24,323, respectively, and my quarterly risky level of 28,401. The "date of the high" shows that seven Dow stocks set new 2018 highs on Friday and four are Dogs.



from Biotech News
Share:

HC Wainwright Analysts Give Avino Silver & Gold Mines (ASM) a $3.00 Price Target

HC Wainwright Analysts Give Avino Silver & Gold Mines (ASM) a $3.00 Price Target


The firm currently has a buy rating on the basic materials company's stock. Other equities research analysts also recently issued research reports about the company.



from Biotech News
Share:

VIB Accelerates Therapeutic Biologics Discovery with Geneious Biologics

VIB Accelerates Therapeutic Biologics Discovery with Geneious Biologics


Nov 12, 2018--Geneious Biologics, an enterprise software solution for companies engaged in screening of antibodies and antibody-like molecules, has been chosen by the VIB to support therapeutic biologics discovery at its Discovery Sciences group. Bruno Dombrecht, Expert Scientist at VIB Discovery Sciences: "Geneious Biologics will help us scale-up our screening efforts.



from Biotech News
Share:

Oncolytics Biotech Reports 2018 Third Quarter Financial Results and Provides Corporate Update

Oncolytics Biotech Reports 2018 Third Quarter Financial Results and Provides Corporate Update


Oncolytics BiotechA Inc. , currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announced financial results and operational highlights for the quarter ended September 30, 2018. All dollar amounts are Canadian unless otherwise noted.



from Biotech News
Share:

Moleculin Biotech Inc (MBRX) Short Interest Update

Moleculin Biotech Inc (MBRX) Short Interest Update


Moleculin Biotech Inc was the target of a significant drop in short interest during the month of October. As of October 31st, there was short interest totalling 740,559 shares, a drop of 29.4% from the October 15th total of 1,048,748 shares.



from Biotech News
Share:

Motley Fool: A biotech bargain? - Sun, 11 Nov 2018 PST

Motley Fool: A biotech bargain? - Sun, 11 Nov 2018 PST


Celgene has several years in which it still can profit handsomely from its multiple myeloma drug Revlimid, one of the best-selling drugs in the world. Celgene has several years in which it still can profit handsomely from its multiple myeloma drug Revlimid, one of the best-selling drugs in the world.



from Biotech News
Share:

Oncolytics Biotech (ONCY) Upgraded to Buy at ValuEngine

Oncolytics Biotech (ONCY) Upgraded to Buy at ValuEngine


Separately, LADENBURG THALM/SH SH assumed coverage on Oncolytics Biotech in a research note on Monday, October 1st. They set a buy rating for the company.



from Biotech News
Share:

Pharmacy News Digest

Архив блога